The independent source for health policy research, polling, and news.
7,481 - 7,500 of 15,449 Results
A person's ZIP code can be as important to her health as her genetic code. One large health system has begun to tackle the social challenges that influence a person's health by asking questions and giving extra help to people in need.
Some drug courts offer participants a full range of evidence-based treatment, including medication-assisted treatment. Others don't allow addiction medications at all. And some permit just one: Vivitrol.
The new law will help people with chronic conditions that require multiple prescriptions cut down on their shuttles to the drug store and could improve adherence to their drugs.
Federal records show that 2,573 hospitals around the country will have their Medicare payments reduced because they have too many patients readmitted.
Response times for emergency medical service units are about twice as long in rural areas as in urban areas, researchers say, underscoring the need for trained lay people to provide first aid until professional help arrives.
The market for wound care products booms among a growing older and diabetic patient pool, but many treatments are untested and funding for research falls short.
Court allows state attorneys general to join a pending legal challenge to keep billions in subsidies flowing to consumers and insurers, despite the Trump administration’s resistance.
The nation’s second-largest insurer is shrinking its presence on Obamacare exchanges and in the broader individual market in response to prevailing uncertainty. California is just the latest — and the biggest — example.
The figure could be higher if President Trump ends an important consumer subsidy, which he has threatened to do. The exchange also announced that Anthem Blue Cross will pull out of Covered California and the overall individual market in 16 of the 19 regions it currently serves.
The FDA granted approval for Spinraza in late December for use on children and adults with spinal muscular atrophy. Insurance coverage is mostly focused on infants and children.
The high cost of Spinraza, a new and promising treatment for spinal muscular atrophy, highlights how the cost-benefit analysis insurers use to make drug coverage decisions plays out in human terms.
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Sarah Kliff of Vox.com, and Mary Agnes Carey of Kaiser Health News discuss what happens now in the wake of the apparent demise of the Republican-only repeal and replace efforts for the Affordable Care Act.
By taking aim at the subsidies received by some congressional staff members who, under the Affordable Care Act, are mandated to get their health coverage from the Obamacare exchanges, the president reignited an old fight.
Only about a third of U.S. adults have advance directives in place to guide the care they receive in the event that they are unable to make their own decisions about life-sustaining medical treatments.
Tighter Medicaid budgets could jeopardize states’ home-based services that help older adults and disabled people live in their homes instead of more expensive nursing homes.
The Trump administration is poised to grant states waivers that some critics say could change the shape of the program.
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Sarah Kliff of Vox.com, and Mary Agnes Carey of Kaiser Health News deconstruct the drama leading to the middle-of-the-night collapse of Senate Republicans’ last-ditch effort to overhaul the Affordable Care Act.
As postmortems mount regarding the collapse of the Senate Republican health plan, it’s clear how complex political and policy issues worked against the replacement effort.
The Trump administration has a variety of mechanisms at its disposal that could undermine the insurance exchanges.
The Trump administration has a variety of mechanisms at its disposal that could undermine the insurance exchanges.
© 2026 KFF